Scott Akamine is Chief Legal Officer of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of CERE, which is worth approximately $0. The most recent transaction as insider was on Aug 01, 2024, when has been sold 7,527 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Scott Akamine Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2024
SELL
Sale (or disposition) back to the issuer
-
7,527 Reduced 100.0%
0 Common Stock
Dec 20 2023
SELL
Open market or private sale
$292,922 $41.42 p/Share
7,072 Reduced 49.42%
7,237 Common Stock
Dec 19 2023
BUY
Exercise of conversion of derivative security
-
13,796 Added 49.09%
14,309 Common Stock
Dec 07 2023
SELL
Open market or private sale
$413,700 $41.37 p/Share
10,000 Reduced 95.12%
513 Common Stock
Dec 07 2023
BUY
Exercise of conversion of derivative security
$131,700 $13.17 p/Share
10,000 Added 48.75%
10,513 Common Stock
Dec 05 2023
SELL
Open market or private sale
$262,500 $35.0 p/Share
7,500 Reduced 93.6%
513 Common Stock
Dec 05 2023
BUY
Exercise of conversion of derivative security
$98,775 $13.17 p/Share
7,500 Added 48.35%
8,013 Common Stock
Aug 08 2022
SELL
Open market or private sale
$400,000 $40.0 p/Share
10,000 Reduced 100.0%
0 Common Stock
Aug 08 2022
BUY
Exercise of conversion of derivative security
$131,700 $13.17 p/Share
10,000 Added 50.0%
10,000 Common Stock
SA

Scott Akamine

Chief Legal Officer
Cambridge, MA

Track Institutional and Insider Activities on CERE

Follow Cerevel Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERE shares.

Notify only if
Any

Insider Trading

Get notified when an Cerevel Therapeutics Holdings, Inc. insider buys or sells CERE shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Cerevel Therapeutics Holdings, Inc.

Track Activities on CERE